Compliance
This section focuses on health care compliance and regulations – both national and state – including the ACA. It includes changes in health care law, regulation, and court decisions and their impact on health insurance professionals, employers, and individuals.
The Biden administration issued a proposed rule Tuesday that aims to shed light on the price of prescription drugs covered by Medicaid. Under the proposal (PDF), pharmacy benefit managers, or pharmacy middlemen, that contract with Medicaid would have to disclose the prices they pay for medications in an effort to improve price transparency and pull the reins on ...
A key House panel advanced a slew of healthcare bills during a busy Wednesday on the Hill for health policy.
The federal government is continuing to debate a response to the looming debt limit deadline, and, should that ceiling be breached, it has significant implications for the healthcare industry.
In a ruling issued this week, the Los Angeles Superior Court upheld the constitutionality of a state law requiring health plans to fairly reimburse health care providers for the costs of COVID-19 testing during the COVID-19 state of emergency.
Key progressives in the House and Senate have revived the fight in Congress over "Medicare for All," a single-payer health system based on the Medicare program.
A House Energy and Commerce Committee health markup on Wednesday offered more evidence that price transparency and pharmacy benefit manager regulation are two issues that have enough bipartisan support to move ahead in this Congress. Among the measures the panel advanced on a unanimous 27-0 vote: Codifying and strengthening Trump-era rules for hospitals and insurers to make ...
The Federal Trade Commission issued a warning Thursday about companies’ use of consumers’ biometric information such as facial recognition technology, saying it raises “significant consumer privacy and data security concerns.” Why it matters: The warning comes as a growing number of companies amass data based on individuals’ physiological features which could be used to infer consumers’ health or ...
A federal appeals court Monday partially paused a ruling from a Texas district court judge that jeopardized access to free preventive care for 150 million Americans.
A key Senate panel advanced a package of bipartisan bills aimed at improving generic drug competition and reforming the business practices of pharmacy benefit managers (PBMs).
The U.S. government on Thursday will end the COVID-19 Public Health Emergency that allowed millions of Americans to receive vaccines, tests and treatments at no cost. The emergency is also tied to telehealth flexibilities, Medicaid enrollment safeguards, and the ability of government health agencies to collect data on the spread of the coronavirus.